Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-26

Clinical Trial Update: A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the combination of ceftazidime and fosfomycin versus ceftazidime alone in hospitalized adults with suspected severe Gram-negativ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosfomycin (Fosfomycin)
  • ceftazidime (ceftazidime)

Snippet

Sponsor: Angela HUTTNER | Conditions: Gram Negative Infections, Sepsis and Septic Shock | Phase 3 | Status: RECRUITING